Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1986 1
1991 1
1993 2
1994 1
1996 1
1997 1
1998 4
1999 2
2000 2
2001 5
2002 6
2003 5
2004 9
2005 2
2006 2
2007 2
2008 4
2009 4
2010 6
2011 5
2012 3
2013 4
2014 8
2015 6
2016 3
2017 5
2018 8
2019 10
2020 14
2021 10
2022 18
2023 15
2024 10
2025 20
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Migraine.
Ferrari MD, Goadsby PJ, Burstein R, Kurth T, Ayata C, Charles A, Ashina M, van den Maagdenberg AMJM, Dodick DW. Ferrari MD, et al. Nat Rev Dis Primers. 2022 Jan 13;8(1):2. doi: 10.1038/s41572-021-00328-4. Nat Rev Dis Primers. 2022. PMID: 35027572 Review.
Management includes analgesics or NSAIDs for mild attacks, and, for moderate or severe attacks, triptans or 5HT(1B/1D) receptor agonists. Because of cardiovascular safety concerns, unreliable efficacy and tolerability issues, use of ergots to ab …
Management includes analgesics or NSAIDs for mild attacks, and, for moderate or severe attacks, triptans or 5HT(1B/1D) receptor …
FBN1-Related Marfan Syndrome.
Dietz H. Dietz H. 2001 Apr 18 [updated 2022 Feb 17]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. 2001 Apr 18 [updated 2022 Feb 17]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. PMID: 20301510 Free Books & Documents. Review.
The major morbidity and early mortality in Marfan syndrome relate to the cardiovascular system and include dilatation of the aorta at the level of the sinuses of Valsalva (predisposing to aortic tear and rupture), mitral valve prolapse with or without regurgitation, …
The major morbidity and early mortality in Marfan syndrome relate to the cardiovascular system and include dilatation of the a …
Cardiovascular safety of psychedelic medicine: current status and future directions.
Wsół A. Wsół A. Pharmacol Rep. 2023 Dec;75(6):1362-1380. doi: 10.1007/s43440-023-00539-4. Epub 2023 Oct 24. Pharmacol Rep. 2023. PMID: 37874530 Free PMC article. Review.
Experimental studies provide inconsistent information on the potential cardiovascular effects and toxicity of psychedelics. Data from clinical trials point to the relative cardiovascular safety of psychedelic-assisted therapies in the population of "healthy" …
Experimental studies provide inconsistent information on the potential cardiovascular effects and toxicity of psychedelics. Data from …
Impacts of shift work on sleep and circadian rhythms.
Boivin DB, Boudreau P. Boivin DB, et al. Pathol Biol (Paris). 2014 Oct;62(5):292-301. doi: 10.1016/j.patbio.2014.08.001. Epub 2014 Sep 20. Pathol Biol (Paris). 2014. PMID: 25246026 Review.
Impaired vigilance and performance occur around times of increased sleepiness and can seriously compromise workers' health and safety. Indeed, workers suffering from a shift work sleep-wake disorder can fall asleep involuntarily at work or while driving back home after a n …
Impaired vigilance and performance occur around times of increased sleepiness and can seriously compromise workers' health and safety …
Cardiovascular safety of triptans.
Dodick DW, Papademetriou V. Dodick DW, et al. Cephalalgia. 2004 Jul;24(7):513-4. doi: 10.1111/j.1468-2982.2003.00714.x. Cephalalgia. 2004. PMID: 15196291 No abstract available.
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment.
Pellesi L, Jedie B, Barhum F, Al-Abdullah S, Martelletti P, Xiao Z. Pellesi L, et al. Pain Manag. 2025 May;15(5):279-284. doi: 10.1080/17581869.2025.2494494. Epub 2025 Apr 16. Pain Manag. 2025. PMID: 40238598 Free PMC article. Review.
Gepants are recommended for the acute treatment of migraine in individuals who do not respond to triptan monotherapy or combination therapy, who experience only partial effectiveness, or who cannot tolerate or have contraindications to triptans. ...Paracetamol, alth …
Gepants are recommended for the acute treatment of migraine in individuals who do not respond to triptan monotherapy or combination t …
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial.
Hordinsky M, Hebert AA, Gooderham M, Kwon O, Murashkin N, Fang H, Harada K, Law E, Wajsbrot D, Takiya L, Zwillich SH, Wolk R, Tran H. Hordinsky M, et al. Pediatr Dermatol. 2023 Nov-Dec;40(6):1003-1009. doi: 10.1111/pde.15378. Epub 2023 Jul 17. Pediatr Dermatol. 2023. PMID: 37455588 Clinical Trial.
The most common adverse events in adolescents were headache, acne, and nasopharyngitis. No deaths, major adverse cardiovascular events, malignancies, pulmonary embolisms, opportunistic infections, or herpes zoster infections were reported. CONCLUSION: Ritlecitinib treatmen …
The most common adverse events in adolescents were headache, acne, and nasopharyngitis. No deaths, major adverse cardiovascular event …
A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation.
Tack J, Derakhchan K, Gabriel A, Spalding W, Terreri B, Youssef A, Kreidieh B, Kowey PR, Boules M. Tack J, et al. Am J Gastroenterol. 2023 Jun 1;118(6):955-960. doi: 10.14309/ajg.0000000000002249. Epub 2023 Mar 16. Am J Gastroenterol. 2023. PMID: 36927957 Free PMC article. Review.
Prokinetic agents, specifically 5-hydroxytryptamine type 4 (5-HT 4 ) receptor agonists, have been shown to provide relief in chronic idiopathic constipation (CIC). The first-generation 5-HT 4 agonists were initially withdrawn from use owing to associations wi …
Prokinetic agents, specifically 5-hydroxytryptamine type 4 (5-HT 4 ) receptor agonists, have been shown to provide relief in c …
184 results